New York Medical Marijuana Law

Status

 

Operational

Law Signed:

2014

QUALIFYING CONDITIONS

  • Acute pain management
  • Amyotrophic Lateral Sclerosis (ALS)
  • Cancer
  • Chronic pain
  • Epilepsy
  • HIV/AIDS
  • Huntington’s Disease
  • Inflammatory bowel disease
  • Parkinson’s Disease
  • Post-Traumatic Stress Disorder
  • Multiple Sclerosis
  • Neuropathies
  • Opioid substitution
  • Spinal cord damage

PATIENT POSSESSION LIMITS

As initially implemented, the law permits qualified patients to possess a 30 day supply of cannabis-infused, non-smokable products. but only non-smokable preparations allowed. Regulations announced by the Department of Health in 2017 states, “[R]egistered organizations will be allowed to manufacture and distribute additional products including topicals such as lotions, ointments and patches, as well as solid and semi-solid products including chewable and effervescent tablets and lozenges. Certain non-smokable forms of ground plant material will also be permissible for manufacture and distribution.”

HOME CULTIVATION

No

STATE-LICENSED DISPENSARIES

Yes, as initially enacted, five producers of cannabis-based preparations and up to 20 dispensing centers were to be licensed by the state. In 2017, the Department of Health registered five additional entities to manufacture and dispense cannabis-infused products.

STATE-LICENSED DISPENSARIES OPERATIONAL

Yes

CAREGIVERS

Yes, each certified patient may have up to two caregivers, and each caregiver may serve no more than five certified patients.

ESTIMATED NUMBER OF REGISTERED PATIENTS

RECIPROCITY

No